HAC plans to transfer its 40% equity stake in its controlling subsidiary, Fushan Chuan
I'm PortAI, I can summarize articles.
HAC plans to transfer 40% equity of its holding subsidiary Fushan Chuan due to insufficient market competitiveness, lack of synergy between the biotechnology business and HAC's core business, and a continuous decline in operating income over the past three years. This equity transfer aims to optimize resource allocation, reduce management costs, and improve asset operation efficiency
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments